Literature DB >> 33374388

IBS-Symptoms in IBD Patients-Manifestation of Concomitant or Different Entities.

Patrycja Szałwińska1, Jakub Włodarczyk1,2, Antonino Spinelli3,4, Jakub Fichna1, Marcin Włodarczyk2.   

Abstract

Irritable bowel syndrome (IBS) is a functional heterogenous disease with a multifactorial pathogenesis. It is characterized by abdominal pain, discomfort, and alteration in gut motility. The occurrence of similar symptoms was observed in patients in clinical remission of inflammatory bowel diseases (IBD) that is Crohn's disease (CD) and ulcerative colitis (UC), which pathogenesis is also not fully understood. Hence, arose the question if these symptoms are "true IBS" imposed on IBD, or is it a subclinical form of IBD or even pre-IBD? In this article, based on a narrative overview of the literature, we try to find an answer to this query by discussing the pathogenesis and overlaps between these conditions.

Entities:  

Keywords:  fecal calprotectin; gut–brain axis; inflammation; inflammatory bowel diseases; irritable bowel symptoms; irritable bowel syndrome; remission

Year:  2020        PMID: 33374388     DOI: 10.3390/jcm10010031

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  6 in total

1.  Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients.

Authors:  Marlijne C G de Graaf; Corinne E G M Spooren; Evelien M B Hendrix; Martine A M Hesselink; Edith J M Feskens; Agnieszka Smolinska; Daniel Keszthelyi; Marieke J Pierik; Zlatan Mujagic; Daisy M A E Jonkers
Journal:  Nutrients       Date:  2022-05-06       Impact factor: 6.706

2.  Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.

Authors:  Martina Ledergerber; Brian M Lang; Henriette Heinrich; Luc Biedermann; Stefan Begré; Jonas Zeitz; Niklas Krupka; Andreas Rickenbacher; Matthias Turina; Thomas Greuter; Philipp Schreiner; René Roth; Alexander Siebenhüner; Stephan R Vavricka; Gerhard Rogler; Niko Beerenwinkel; Benjamin Misselwitz
Journal:  BMC Gastroenterol       Date:  2021-02-05       Impact factor: 3.067

3.  Protective effects of curcumin against rat intestinal inflammation‑related motility disorders.

Authors:  Yang Yao; Ranyuan Luo; Shu Xiong; Chang Zhang; Yukun Zhang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

4.  Overlap between irritable bowel syndrome and common gastrointestinal diagnoses: a retrospective cohort study of 29,553 outpatients in Germany.

Authors:  Sven H Loosen; Karel Kostev; Tom Luedde; Christoph Roderburg; Markus S Jördens
Journal:  BMC Gastroenterol       Date:  2022-02-05       Impact factor: 3.067

5.  Endoscopy for assessment of mucosal healing in ulcerative colitis: time bound or response guided?

Authors:  Ajit Sood; Ramit Mahajan; Arshdeep Singh; Vandana Midha; Varun Mehta
Journal:  Intest Res       Date:  2022-02-08

6.  Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis.

Authors:  Cecilia Ceccherini; Sara Daniotti; Claudia Bearzi; Ilaria Re
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.